These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 17945002)

  • 1. Implication of BRCA2 -26G>A 5' untranslated region polymorphism in susceptibility to sporadic breast cancer and its modulation by p53 codon 72 Arg>Pro polymorphism.
    Gochhait S; Bukhari SI; Bairwa N; Vadhera S; Darvishi K; Raish M; Gupta P; Husain SA; Bamezai RN
    Breast Cancer Res; 2007; 9(5):R71. PubMed ID: 17945002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.
    Hedau S; Jain N; Husain SA; Mandal AK; Ray G; Shahid M; Kant R; Gupta V; Shukla NK; Deo SS; Das BC
    Breast Cancer Res Treat; 2004 Nov; 88(2):177-86. PubMed ID: 15564800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evaluation of the polymorphisms Ins16bp and Arg72Pro in p53 as breast cancer risk modifiers in BRCA1 and BRCA2 mutation carriers.
    Osorio A; Pollán M; Pita G; Schmutzler RK; Versmold B; Engel C; Meindl A; Arnold N; Preisler-Adams S; Niederacher D; Hofmann W; Gadzicki D; Jakubowska A; Hamann U; Lubinski J; Toloczko-Grabarek A; Cybulski C; Debniak T; Llort G; Yannoukakos D; Díez O; Peissel B; Peterlongo P; Radice P; Heikkinen T; Nevanlinna H; Mai PL; Loud JT; McGuffog L; Antoniou AC; Benitez J;
    Br J Cancer; 2008 Sep; 99(6):974-7. PubMed ID: 18781154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Dominantly Inherited 5' UTR Variant Causing Methylation-Associated Silencing of BRCA1 as a Cause of Breast and Ovarian Cancer.
    Evans DGR; van Veen EM; Byers HJ; Wallace AJ; Ellingford JM; Beaman G; Santoyo-Lopez J; Aitman TJ; Eccles DM; Lalloo FI; Smith MJ; Newman WG
    Am J Hum Genet; 2018 Aug; 103(2):213-220. PubMed ID: 30075112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 exon 4 (codon 72) polymorphism and exon 7 (codon 249) mutation in breast cancer patients in southern region (Madurai) of Tamil Nadu.
    Vijayaraman KP; Veluchamy M; Murugesan P; Shanmugiah KP; Kasi PD
    Asian Pac J Cancer Prev; 2012; 13(2):511-6. PubMed ID: 22524816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 codon 72 polymorphism interactions with dietary and tobacco related habits and risk of stomach cancer in Mizoram, India.
    Malakar M; Devi KR; Phukan RK; Kaur T; Deka M; Puia L; Sailo L; Lalhmangaihi T; Barua D; Rajguru SK; Mahanta J; Narain K
    Asian Pac J Cancer Prev; 2014; 15(2):717-23. PubMed ID: 24568485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of a p53 codon 72 gene polymorphism with environmental factors and risk of lung cancer: a case control study in Mizoram and Manipur, a high incidence region in North East India.
    Saikia BJ; Das M; Sharma SK; Sekhon GS; Zomawia E; Singh YM; Mahanta J; Phukan RK
    Asian Pac J Cancer Prev; 2014; 15(24):10653-8. PubMed ID: 25605155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p16 gene silencing along with p53 single-nucleotide polymorphism and risk of esophageal cancer in Northeast India.
    Das M; Sharma SK; Sekhon GS; Mahanta J; Phukan RK; Jalan BK
    Tumour Biol; 2017 May; 39(5):1010428317698384. PubMed ID: 28459370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TP53 (rs1042522, rs28934571) and TP21 (rs1801270, rs1059234) Polymorphisms and Risk of Breast Cancer among Rural Women of Maharashtra: Findings from a Hospital Based Case- Control Study.
    Datkhile KD; Bhosale SJ; Durgawale PP; Jagdale NJ; More AL; Gudur RA; Gudur AK; Patil SR
    Asian Pac J Cancer Prev; 2023 May; 24(5):1611-1619. PubMed ID: 37247280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TP53 codon 72 polymorphism and breast cancer risk in Bangladeshi population.
    Hossain A; Murshid GMM; Zilani MNH; Islam F; Sultana R; Sultana T; Hossain MG; Rahman MM
    Breast Cancer; 2017 Jul; 24(4):571-578. PubMed ID: 27837441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational analysis of the BRCA2 gene in breast carcinoma patients of Kashmiri descent.
    Ayub SG; Rasool S; Ayub T; Khan SN; Wani KA; Andrabi KI
    Mol Med Rep; 2014 Feb; 9(2):749-53. PubMed ID: 24337145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation on the role of p53 codon 72 polymorphism and interactions with tobacco, betel quid, and alcohol in susceptibility to cancers in a high-risk population from North East India.
    Ihsan R; Devi TR; Yadav DS; Mishra AK; Sharma J; Zomawia E; Verma Y; Phukan R; Mahanta J; Kataki AC; Kapur S; Saxena S
    DNA Cell Biol; 2011 Mar; 30(3):163-71. PubMed ID: 21043833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P53 codon 72 polymorphism and risk of gastric cancer in a Chinese population.
    Shen H; Solari A; Wang X; Zhang Z; Xu Y; Wang L; Hu X; Guo J; Wei Q
    Oncol Rep; 2004 May; 11(5):1115-20. PubMed ID: 15069555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 Codon 72 polymorphism predicts the pathologic response to neoadjuvant chemotherapy in patients with breast cancer.
    Xu Y; Yao L; Ouyang T; Li J; Wang T; Fan Z; Lin B; Lu Y; Xie Y
    Clin Cancer Res; 2005 Oct; 11(20):7328-33. PubMed ID: 16243804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms in thymidylate synthase gene and susceptibility to breast cancer in a Chinese population: a case-control analysis.
    Zhai X; Gao J; Hu Z; Tang J; Qin J; Wang S; Wang X; Jin G; Liu J; Chen W; Chen F; Wang X; Wei Q; Shen H
    BMC Cancer; 2006 May; 6():138. PubMed ID: 16723031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic polymorphisms of p53 codon 72 and bladder cancer susceptibility: a hospital-based case-control study.
    Zhang R; Chen W; Zhang W; Jiang Q; Liu C; Lin Y; Hu Z; Yu S; Xu G
    Genet Test Mol Biomarkers; 2011 May; 15(5):337-41. PubMed ID: 21291320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Codon 72 and G13964C intron 6 polymorphisms of TP53 in relation to development and progression of breast cancer in India.
    Surekha D; Sailaja K; Rao DN; Padma T; Raghunadharao D; Vishnupriya S
    Asian Pac J Cancer Prev; 2011; 12(8):1893-8. PubMed ID: 22292621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No association of TP53 codon 72 and intron 3 16-bp duplication polymorphisms with breast cancer risk in Chinese Han women: new evidence from a population-based case-control investigation.
    Hao W; Xu X; Shi H; Zhang C; Chen X
    Eur J Med Res; 2018 Oct; 23(1):47. PubMed ID: 30309383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of BRCA2 polymorphism at codon 784 (Met/Val) with breast cancer risk and prognosis.
    Ishitobi M; Miyoshi Y; Ando A; Hasegawa S; Egawa C; Tamaki Y; Monden M; Noguchi S
    Clin Cancer Res; 2003 Apr; 9(4):1376-80. PubMed ID: 12684407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of p53 codon 72 polymorphism in patients with breast cancer.
    Vieira JO; da Silva ID; Higo PE; Nogueira-de-Souza NC; Gebrim LH
    Eur J Gynaecol Oncol; 2008; 29(4):364-7. PubMed ID: 18714570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.